Carol Beer Benson MD, Presenter: Nothing to Disclose

1) To review the role of the 11-14 week scan in screening for chromosomal abnormalities and birth defects. 2) To provide an update on all aspects of nuchal translucency screening. 3) To demonstrate that combining the 11-14 week scan with maternal biochemistry in the first trimester not only predicts aneuploidy but also adverse pregnancy outcome. 4) To review the current status of other sonographic findings including 3D ultrasound of various fetal malformations. that can be diagnosed in the first trimester.

http://www.mfmedicine.com/SyllabusForRSNA.aspx

Benson, C, The 10 - 14-Week Scan: An Update.  Radiological Society of North America 2008 Scientific Assembly and Annual Meeting, February 18 - February 20, 2008 ,Chicago IL. http://archive.rsna.org/2008/5000190.html